John G Ullman & Associates Inc Jazz Pharmaceuticals PLC Transaction History
John G Ullman & Associates Inc
- $624 Million
- Q2 2025
A detailed history of John G Ullman & Associates Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, John G Ullman & Associates Inc holds 35,910 shares of JAZZ stock, worth $4.17 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
35,910
Previous 39,118
8.2%
Holding current value
$4.17 Million
Previous $4.86 Million
21.54%
% of portfolio
0.61%
Previous 0.81%
Shares
6 transactions
Others Institutions Holding JAZZ
# of Institutions
586Shares Held
60.1MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$714 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$699 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$286 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$270 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$228 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.28B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...